Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1426 to 1450 of about 5951

Previous 25

Website Changes

11/24/2017

Ziopharm says its brain cancer drug helped trial patients live more than a year

11/24/2017

Inovio Starts Trial Testing Triple-combo Immunotherapy in Newly-diagnosed Glioblastoma

11/22/2017

Medicenna Presents Updates on Phase 2b Clinical Trial of MDNA55 at the Annual Meeting of the Society of Neuro-Oncology

11/21/2017

High compliance with Optune linked to greatest survival benefit for glioblastoma

11/21/2017

Lomustine and Bevacizumab in Progressive Glioblastoma.

11/21/2017

Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.

11/21/2017

DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting

11/17/2017

Patients Who Used Optune® More Than 90 Percent of the Time Had the Greatest Chance of Survival in Novocure’s EF-14 Trial: A Median Survival of 24.9 Months from Randomization and a Five-Year Survival of 29.3 Percent

11/17/2017

Toca 5 Trial is now open!

11/17/2017

GBM Heroes Honored By CURE

11/16/2017

National Cancer Institute designates UCLA brain cancer program a site of research excellence

11/15/2017

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

11/15/2017

Medicenna Presents Clinical Data From Previous Phase 1 and 2 Clinical Trials of MDNA55

11/10/2017

Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models

11/07/2017

Liquid Biopsy Spots Aggressive Pediatric Brainstem Cancer Earlier

11/05/2017

Making medicine, not money: How one U of T researcher`s startup is rethinking Big Pharma`s business model

11/05/2017

ONC201 Trial for Histone Mutant Glioma Begins at NYU

11/01/2017

U.S. experts set research agenda to meet `Cancer Moonshot` goals

10/30/2017

Health Beat: MDNA trial for glioblastoma

10/29/2017

10/28/2017

Durable Responses Observed in Recurrent High Grade Glioma (rHGG) with Toca 511 & Toca FC Treatment

10/26/2017

Tocagen to Accelerate Toca 511 & Toca FC Development into Pivotal Phase 3 Trial

10/25/2017

Optune trials opens for adult patients with low grade gliomas and pediatric patients with high grade gliomas

10/24/2017

Incidental findings abound on brain scans of the general pediatric population

10/18/2017

Arsenic identified as a potential treatment for brain cancer

Our privacy / cookie policy has changed.
Click HERE to read it!